Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Jun J. Mao

Research Funding: Tibet Cheezheng Tibetan Medicine Co Ltd (Inst)

Nofisat Ismaila

Employment: GlaxoSmithKline (I)

Stock and Other Ownership Interests: GlaxoSmithKline (I)

Ting Bao

Research Funding: Merck

Eric L. Garland

Consulting or Advisory Role: BehaVR LLC

Patents, Royalties, Other Intellectual Property: I am a licensor to BehaVR LLC, I have licensed my Mindfulness-Oriented Recovery Enhancement intervention to BehaVR so the company could develop a virtual reality version of the therapy. I receive royalties for this license.

Other Relationship: Myself

Thomas Leblanc

Honoraria: AbbVie, Astellas Pharma, Agilix

Consulting or Advisory Role: Pfizer, AbbVie/Genentech, AstraZeneca, Flatiron Health, Bristol Myers Squibb/Celgene, GlaxoSmithKline, Astellas Pharma, Blue Note Therapeutics

Speakers' Bureau: Agios, AbbVie, Bristol Myers Squibb/Celgene

Research Funding: AstraZeneca (Inst), Jazz Pharmaceuticals (Inst), Bristol Myers Squibb (Inst)

Patents, Royalties, Other Intellectual Property: UpToDate Inc, royalty

Travel, Accommodations, Expenses: Agios, AbbVie/Genentech, Bristol Myers Squibb/Celgene

Richard T. Lee

Research Funding: Merck (Inst), Incyte (Inst), Yivia (Inst)

Uncompensated Relationships: Grow Ohio Pharmaceuticals

Ana Maria Lopez

Research Funding: Bristol Myers Squibb

Charles Loprinzi

Consulting or Advisory Role: PledPharma, Metys Pharmaceuticals, Disarm Therapeutics, OnQuality Pharmaceuticals, NKMax, Mitsubishi Tanabe Pharma, Veloxis, Hengrui Pharmaceutical, Osmol Therapeutics, Grunenthal, Neuropathix, Denali Therapeutics

Research Funding: Bristol Myers Squibb (Inst)

Other Relationship: Cynosure/Hologic

Gary H. Lyman

Honoraria: Sandoz, Partners Healthcare, Squibb, Seattle Genetics, Teva, Jazz Pharmaceuticals

Consulting or Advisory Role: G1 Therapeutics, Samsung Bioepis, BeyondSpring Pharmaceuticals, MSD, Fresenius Kabi

Research Funding: Amgen (Inst)

Viraj A. Master

Honoraria: Ethicon

Kavitha Ramchandran

Consulting or Advisory Role: Drishti, Group Well, Varian Medical Systems

Lynne I. Wagner

Stock and Other Ownership Interests: Johnson & Johnson (I), Lilly (I), Gilead Sciences (I)

Consulting or Advisory Role: Celgene, Athenex

Travel, Accommodations, Expenses: Celgene

Deborah Watkins Bruner

Employment: Emory University

Stock and Other Ownership Interests: AbbVie, Altria, Bristol Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Pfizer, Procter & Gamble, Stryker, Viatris, Walgreens Boots Alliance

Honoraria: American Society of Radiation Oncology (ASTRO), Oncology Nursing Society, Memorial Sloan-Kettering Cancer Center, Alliance, Wilmont Cancer Center

Consulting or Advisory Role: Flatiron Health, Alliance for Clinical Trials in Oncology, University of Rochester

Claudia M. Witt

Research Funding: CERES (Inst), Newsenselab (Inst)

Eduardo Bruera

Research Funding: PharmaCann Inc (Inst)

No other potential conflicts of interest were reported.